Paroxetine may prevent ROS damage in diabetes patients

12/16/2012 | RedOrbit

The antidepressant paroxetine appeared to stave off reactive oxygen species molecules associated with hyperglycemia in diabetes patients, according to a study in Diabetes. Researchers said the drug prevents ROS damage by lowering concentrations and suppressing production of superoxide.

View Full Article in:

RedOrbit

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA